Alexander Nowak
Stock Analyst at Craig-Hallum
(3.96)
# 702
Out of 4,479 analysts
36
Total ratings
59.09%
Success rate
9.35%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Assumes: Buy | $25 → $27 | $16.19 | +66.77% | 2 | May 16, 2024 | |
| CVRX CVRx, Inc. | Assumes: Buy | $30 → $23 | $11.78 | +95.25% | 2 | May 1, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $14.90 | +0.67% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $2.80 | +185.71% | 3 | Apr 24, 2024 | |
| NTRA Natera | Assumes: Buy | $117 | $110.70 | +5.69% | 2 | Apr 8, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $1.15 | -13.04% | 3 | Apr 1, 2024 | |
| BVS Bioventus | Maintains: Buy | $6 → $9 | $5.78 | +55.71% | 4 | Mar 13, 2024 | |
| QDEL QuidelOrtho | Downgrades: Hold | n/a | $31.36 | - | 4 | Feb 14, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $6.32 | +184.81% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $39.15 | +27.71% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $14 → $8 | $1.18 | +577.97% | 1 | May 12, 2023 | |
| EXAS Exact Sciences | Downgrades: Hold | n/a | $43.17 | - | 1 | Oct 19, 2022 | |
| NMTC NeuroOne Medical Technologies | Downgrades: Hold | n/a | $0.87 | - | 2 | Mar 28, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $11 | $1.76 | +525.00% | 1 | Jan 5, 2022 | |
| TECH Bio-Techne | Maintains: Buy | n/a | $71.24 | - | 1 | Feb 3, 2021 | |
| SENS Senseonics Holdings | Downgrades: Sell | n/a | $0.39 | - | 2 | Jan 20, 2021 | |
| VVOS Vivos Therapeutics | Initiates: Buy | $300 | $2.38 | +12,505.04% | 1 | Jan 11, 2021 | |
| INFU InfuSystem Holdings | Initiates: Buy | n/a | $6.67 | - | 1 | Aug 31, 2020 |
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $16.19
Upside: +66.77%
CVRx, Inc.
May 1, 2024
Assumes: Buy
Price Target: $30 → $23
Current: $11.78
Upside: +95.25%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $14.90
Upside: +0.67%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $2.80
Upside: +185.71%
Natera
Apr 8, 2024
Assumes: Buy
Price Target: $117
Current: $110.70
Upside: +5.69%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $1.15
Upside: -13.04%
Bioventus
Mar 13, 2024
Maintains: Buy
Price Target: $6 → $9
Current: $5.78
Upside: +55.71%
QuidelOrtho
Feb 14, 2024
Downgrades: Hold
Price Target: n/a
Current: $31.36
Upside: -
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $6.32
Upside: +184.81%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $39.15
Upside: +27.71%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $1.18
Upside: +577.97%
Exact Sciences
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $43.17
Upside: -
NeuroOne Medical Technologies
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.87
Upside: -
Stereotaxis
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.76
Upside: +525.00%
Bio-Techne
Feb 3, 2021
Maintains: Buy
Price Target: n/a
Current: $71.24
Upside: -
Senseonics Holdings
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.39
Upside: -
Vivos Therapeutics
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.38
Upside: +12,505.04%
InfuSystem Holdings
Aug 31, 2020
Initiates: Buy
Price Target: n/a
Current: $6.67
Upside: -